| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/12/2006 | US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity |
| 10/12/2006 | US20060228415 Comprising core of bupropion hydrochloride, binder, lubricant, control releasing coat, moisture barrier surrounding coat; advantage of tablets of invention not afforded by prior art commercially available tablets is that they allow for a once daily administration and do not exhibit food effect |
| 10/12/2006 | US20060228414 Method for the preparation of controlled release formulations |
| 10/12/2006 | US20060228383 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol |
| 10/12/2006 | US20060228373 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 10/12/2006 | US20060228328 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 10/12/2006 | US20060228326 Active specific immunotherapy of cancer metastasis |
| 10/12/2006 | US20060228314 Cosmetic compositions containing phenyl silicones |
| 10/12/2006 | US20060226234 Pharmaceutical dosage forms having overt and covert markings for identification and authentification |
| 10/11/2006 | EP1709961A1 Use of Docosahexaenoic Acid and/or Arachidonic Acid for preventing or treating respiratory infections in infants |
| 10/11/2006 | EP1709187A1 Systems and methods for blood glucose sensing |
| 10/11/2006 | EP1708751A2 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 10/11/2006 | EP1708748A2 Influenza immunogen and vaccine |
| 10/11/2006 | EP1708717A2 Treatment of allergic rhinitis and asthma |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1649066A4 Multiplexed molecular beacon assay for detection of pathogens |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/11/2006 | CN1846000A HPV CD8+ T-cell epitopes |
| 10/11/2006 | CN1845914A Ophthalmic compositions for treating ocular hypertension |
| 10/11/2006 | CN1845757A Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 10/11/2006 | CN1845750A Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| 10/11/2006 | CN1845676A Compositions related to a novel endophytic fungi and methods of use |
| 10/11/2006 | CN1845674A Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 10/11/2006 | CN1279165C Inflenza vaccine composition |
| 10/11/2006 | CN1279023C Indole-3-sulphur derivatives |
| 10/10/2006 | US7119096 Anticancer agents |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7118770 Plant extracts formed via steam distillation of essential oils |
| 10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 10/10/2006 | CA2240526C Compositions containing an antifungal and a sulfur compound |
| 10/07/2006 | CA2516873A1 Method for preventing or treating respiratory infections in infants |
| 10/05/2006 | WO2005070081A3 Methods of using zonisamide as an adjunctive therapy for partial seizures |
| 10/05/2006 | WO2005055938A3 A low-weight ultra-thin flexible radiation attenuation composition |
| 10/05/2006 | WO2005039490A3 Methods and compositions for treating cancer |
| 10/05/2006 | WO2005027837A3 Substituted sulfonamides |
| 10/05/2006 | WO2005020896A3 N,n-dihalogenated amino acids and derivatives |
| 10/05/2006 | WO2005013893A3 Cancer related genes |
| 10/05/2006 | WO2005002500A3 Inhibitors of coronavirus |
| 10/05/2006 | WO2004108094A3 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 10/05/2006 | WO2004064774A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223879 Non-steroidal farnesoid x receptor modulators |
| 10/05/2006 | US20060223729 Photodynamic inactivation of bacterial spores |
| 10/05/2006 | US20060223180 Methods to mobilize progenitor/stem cells |
| 10/05/2006 | US20060223055 Methods and compositions for treatment of viral lnfection |
| 10/05/2006 | US20060223050 Therapeutic platelets and methods |
| 10/05/2006 | US20060222723 Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 10/05/2006 | US20060222664 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 10/05/2006 | US20060222588 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 10/04/2006 | EP1706098A2 Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
| 10/04/2006 | EP1675886A4 Water-soluble polyamioamides as sunscreen agents |
| 10/04/2006 | EP1545206A4 Compositions and products containing enantiomeric equol, and methods for their making |
| 10/04/2006 | EP1458376B1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 10/04/2006 | EP1425008B1 Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics |
| 10/04/2006 | EP1420799B1 Use of atazanavir in hiv therapy |
| 10/04/2006 | EP1054955B1 Compositions comprising viruses and methods for concentrating virus preparations |
| 10/04/2006 | CN1842529A Compounds and compositions as protein kinase inhibitors |
| 10/04/2006 | CN1842526A Benzodiazepine CGRP receptor antagonists |
| 10/04/2006 | CN1842274A Anhydrous silver dihydrogen citrate compositions |
| 10/04/2006 | CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 10/04/2006 | CN1840178A Tumour-specific animal proteins |
| 10/04/2006 | CN1839873A Pharmaceutically active uridine esters |
| 10/03/2006 | US7115666 Analgesics; trauma brain injuries ; antiarthritic agents |
| 10/03/2006 | US7115646 Cyclic diamines and derivatives as factor Xa inhibitors |
| 10/03/2006 | US7115560 of given amino acid sequence, for reducing gastric acid or pepsinogen secretion |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115285 Composition and method for appetite and craving suppression and mood enhancement |
| 10/03/2006 | US7115284 Compositions for diabetes treatment and prophylaxis |
| 10/03/2006 | CA2261879C Aerosol formulations |
| 10/03/2006 | CA2253580C Improvements in or relating to compositions containing creatine |
| 10/03/2006 | CA2205906C In-vivo diagnostic process by near infrared radiation |
| 09/28/2006 | WO2005052134A3 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 09/28/2006 | WO2005016240A3 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 09/28/2006 | WO2004089305A3 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 09/28/2006 | WO2004075830A3 Knockout identification of target-specific sites in peptides |
| 09/28/2006 | WO2004069174A3 Monitoring and treatment of amyotrophic lateral sclerosis |
| 09/28/2006 | WO2004069146A3 L-dopa amide derivatives and uses thereof |
| 09/28/2006 | US20060217563 tetraheterocyclicspiro compound containing pyrazole ring; for treating a variety of autoimmune and inflammatory diseases |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217391 Method of treating functional bowel disorders |
| 09/28/2006 | US20060217341 DNA vaccine formulations |
| 09/28/2006 | US20060217328 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders |
| 09/28/2006 | US20060217325 Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells |
| 09/28/2006 | US20060217323 Substituted indazole-O-glucosides |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060216757 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 09/28/2006 | US20060216364 Composition for Topic Use Containing an Extract of Stryphnodendron... |
| 09/28/2006 | US20060216312 Mutants of replication competent vaccinia virus |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216272 Therapeutic immunization of hiv-infected individuals |
| 09/27/2006 | EP1704227A1 Immortalized hepatocytes |
| 09/27/2006 | EP1703904A2 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 09/27/2006 | EP1123088B1 Sustained-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 09/27/2006 | CN1839121A Hydroxamic acid compounds and methods of use thereof |
| 09/27/2006 | CN1839102A An electric desalination method and structure of a spiral winding electric desalination device |
| 09/27/2006 | CN1838956A 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |